Showing results (11-20 of 144) with videos related to
Sort By:
Pageof 15
Physical Review. E|March 16, 2024
Estimating stable fixed points and Langevin potentials for financial dynamicsTobias Wand, Timo Wiedemann, Jan Harren, et al.Behavioural Brain Research|June 24, 2008
Molecular biology of 5-HT receptorsJason Hannon, Daniel HoyerCurrent Drug Targets|January 2, 2016
Astrocytes: Adhesion Molecules and ImmunomodulationShane Liddelow, Daniel HoyerChemistry & Biodiversity|November 20, 2012
Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter SeebachDaniel Hoyer, Tamas BartfaiDrug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K DevNeuropeptides|November 13, 2013
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?Daniel Hoyer, Laura H JacobsonNaunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 2003
Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophsDavide Cervia, Dominique Fehlmann, Daniel HoyerPsychopharmacology|March 8, 2017
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatmentJose M Palacios, Angel Pazos, Daniel HoyerBritish Journal of Clinical Pharmacology|November 23, 2019
Hypnotics with novel modes of actionDaniel Hoyer, Andrew Allen, Laura H JacobsonPageof 15